DaVita
DVA
#2035
Rank
NZ$16.94 B
Marketcap
NZ$257.02
Share price
-2.25%
Change (1 day)
8.40%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): NZ$17.32

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$17.15. In 2024 the company made an earnings per share (EPS) of NZ$18.69 an increase over its 2023 EPS that were of NZ$12.90.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$17.32-7.33%
2024NZ$18.6944.94%
2023NZ$12.9027.26%
2022NZ$10.13-35.56%
2021NZ$15.7344.1%
2020NZ$10.9119.7%
2019NZ$9.12540.48%
2018NZ$1.42-76.07%
2017NZ$5.95-19.31%
2016NZ$7.37242.52%
2015NZ$2.15-62.87%
2014NZ$5.8013.43%
2013NZ$5.118.45%
2012NZ$4.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$39.78 131.92%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.85 4.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$24.91 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.25-81.08%๐Ÿ‡บ๐Ÿ‡ธ USA